Related Experiment Videos

p53-independent role of MDM2 in TGF-beta1 resistance

P Sun1, P Dong, K Dai

  • 1Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA.

Science (New York, N.Y.)
|December 18, 1998
PubMed

Insights

Murine double minute 2 (MDM2) confers resistance to transforming growth factor-beta (TGF-beta) by impacting p53 and retinoblastoma protein (Rb) pathways. This MDM2 function may promote tumor development by overcoming TGF-beta

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Genetics

Background:

  • Transforming growth factor-beta (TGF-beta) is a crucial regulator of cell proliferation, and its resistance is implicated in tumorigenesis.
  • Understanding the mechanisms of TGF-beta resistance is vital for developing effective cancer therapies.

Purpose of the Study:

  • To identify genes that confer resistance to TGF-beta-induced growth arrest.
  • To elucidate the role of murine double minute 2 (MDM2) in TGF-beta resistance and its potential contribution to tumorigenesis.

Main Methods:

  • A genetic screen was conducted in mink lung epithelial cells to identify complementary DNAs that abrogated TGF-beta sensitivity.
  • Ectopic expression of MDM2 was analyzed for its effect on TGF-beta-induced growth arrest.
  • MDM2 expression levels were assessed in human breast tumor cells in relation to TGF-beta resistance.

Main Results:

  • Ectopic expression of MDM2 rescued TGF-beta-induced growth arrest in a p53-independent manner.
  • MDM2's mechanism involved interference with retinoblastoma susceptibility gene product (Rb)/E2F function.
  • Increased MDM2 expression correlated with TGF-beta resistance in human breast tumor cells.

Conclusions:

  • MDM2 confers TGF-beta resistance, potentially promoting tumorigenesis.
  • MDM2 may act as an oncoprotein by interfering with two key tumor suppressors: p53 and Rb.

Related Concept Videos